Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +47.62%
#3 Akedo Akedo +40.17%
#4 Velvet Velvet +38.60%
#5 Black Phoenix Black Phoenix +34.09%
#6 Cross Cross +26.08%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.46%
#8 Bitway Bitway +15.33%
#9 QANplatform QANplatform +14.56%
#10 Perle Perle +14.17%
Coin of the day
Glidr Glidr
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
MedAvail Holdings, Inc. MedAvail Holdings, Inc.

MedAvail Holdings, Inc.

MDVL
Kedudukan dalam Saham #38563
MedAvail Holdings, Inc. is a pioneer in tech-driven retail pharmacy solutions,... MedAvail Holdings, Inc. is a pioneer in tech-driven retail pharmacy solutions, focusing on both the technology itself and related services. The company designs and markets a range of innovative offerings, including self-service pharmacy units, mobile applications, interactive kiosks, and drive-thru services, all operating across the United States and Canada. Its operations are divided into two main areas: Retail Pharmacy Services and Pharmacy Technology. A flagship product, the MedCenter system, facilitates on-site prescription dispensing in various environments such as medical clinics, retail stores, and employer sites, or any location desiring convenient, integrated pharmacy access. Crucially, it incorporates a secure audio-visual link to a licensed pharmacist, enabling patients to receive their medications directly while benefiting from real-time professional guidance and supervision. MedAvail also manages its own retail pharmacy platform, known as SpotRx. As of the close of 2021, the company had installed 81 MedCenter kiosks. MedAvail Holdings, Inc. maintains its headquarters in Mississauga, Canada.
Harga Saham
$1.41
Disegerakkan terakhir: 2024-03-12
Modal Pasaran
$914.81K
Perubahan (1 hari)
-16.57%
Perubahan (1 tahun)
0.00%
Negara
CA
Perdagangan MedAvail Holdings, Inc. (MDVL)

Kategori

Healthcare
Nisbah P/E bagi MedAvail Holdings, Inc. (MDVL)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini MedAvail Holdings, Inc., nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi MedAvail Holdings, Inc. dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 23.71 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 220.17 -
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.